Annkristin HEINE - Medical Doctor - University of Bonn - Medical Center, Bonn - Haematology Oncology
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
6 "Ann Grobe" profiles | LinkedIn
Erfolg bei Ausschreibung? Advanced Clinician Scientist? – Forschende Mediziner erhalten Förderung durch das BMBF - MINQ Magazin
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient. - Abstract - Europe PMC
CIO Bonn - Lymphomzentrum
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells | BMC Biology | Full Text
Loop | Annkristin Heine
Tückischen Blutkrebs effektiv bekämpfen — Universität Bonn
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie der Universitätsklinikum Bonn
Implementing combinatorial immunotherapeutic regimens against cancer
Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products - Cytotherapy
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells | BMC Biology | Full Text
UKB NewsRoom | Annkristin Heine
Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors
ImmunoSensation / The Immune Sensory System » Details
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
Medicine®
Team | IMMEI
S. Heine, Ann-Kristin Hedmark & Bosse Broberg - Wanderer | Play on Anghami
